Sepracor Says Epilepsy Drug Is Effective, Safe
Three Phase III trials studying Sepracor’s anti-epileptic agent, eslicarbazepine acetate, reduced the frequency of partial seizures in patients with refractory partial epilepsy when combined with other anti-epileptic agents.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.